Literature DB >> 18806352

Do serological tests provide adequate rapid diagnosis of Mycoplasma pneumoniae infection?

Fang-Ching Liu1, Po-Yen Chen, Fang-Liang Huang, Chi-Ren Tsai, Chun-Yi Lee, Chen-Fu Lin.   

Abstract

This study was designed to evaluate the serologic response to Mycoplasma pneumoniae infection. A total of 589 children < or =18 years (190 in the year 2004; 399 in 2005) and 2,073 adults > or = 18 years of age (980 in the year 2004; 1,093 in 2005) with respiratory symptoms underwent serological testing for M. pneumoniae infection. The tests included passive particle agglutination (PA) and enzyme-linked immunosorbent assay (ELISA). The seroprevalence rates of M. pneumoniae infection in the years 2004 and 2005 were 6.9 and 10.1%, respectively. The seropositivity rate was significantly higher in children (29.6% in 2005; 23.7% in 2004) than in adults (2.9% in 2005; 3.7% in 2004) (odds ratio, 8.138 in 2004; 13.923 in 2005; 95% confidence interval, 5.077-13.045 in 2004; 9.220-21.026 in 2005). Paired sera for the PA test were obtained from 32 of 399 children, and 22 of them demonstrated at least fourfold rises in antibody titer. ELISA had a sensitivity of 77.3% and a specificity of 40.0%; PA had a sensitivity of 9.5% and a specificity of 80%. The ELISA test was superior to the PA test in diagnosing acute M. pneumoniae infection in children. Both tests were significantly more sensitive when they were performed 1 week after the onset of infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18806352

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  5 in total

Review 1.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  Microfluidic platform versus conventional real-time polymerase chain reaction for the detection of Mycoplasma pneumoniae in respiratory specimens.

Authors:  Elizabeth Wulff-Burchfield; Wiley A Schell; Allen E Eckhardt; Michael G Pollack; Zhishan Hua; Jeremy L Rouse; Vamsee K Pamula; Vijay Srinivasan; Jonathan L Benton; Barbara D Alexander; David A Wilfret; Monica Kraft; Charles B Cairns; John R Perfect; Thomas G Mitchell
Journal:  Diagn Microbiol Infect Dis       Date:  2010-03-12       Impact factor: 2.803

Review 3.  Acute respiratory infection due to Mycoplasma pneumoniae: current status of diagnostic methods.

Authors:  K Loens; H Goossens; M Ieven
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-06       Impact factor: 3.267

4.  Risk of Mycoplasma pneumoniae-related hepatitis in MP pneumonia pediatric patients: a predictive model construction and assessment.

Authors:  Yuna Bi; Yan Ma; Jinhua Zhuo; Lili Zhang; Liyan Yin; Hongling Sheng; Jie Luan; Tao Li
Journal:  BMC Pediatr       Date:  2021-06-21       Impact factor: 2.125

5.  High seroprevalence of Mycoplasma pneumoniae IgM in acute Q fever by enzyme-linked immunosorbent assay (ELISA).

Authors:  Chung-Hsu Lai; Lin-Li Chang; Jiun-Nong Lin; Wei-Fang Chen; Li-Li Kuo; Hsi-Hsun Lin; Yen-Hsu Chen
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.